Technology
specialist or technician and there is no need for costly pre-operative CT imaging. “The technology assesses the landmarks on the knee, so you don’t have to base your decisions on a CT scan. In addition, the elimination of CT scans from the pre-operative workflow can save time for patients and episode of care costs. There has been a huge amount of interest in the technology,” Gavin explained. The table-mounted, imageless solution
features a streamlined design that integrates into surgeons’ current workflow. The system gives surgeons the control they are used to and allows them to retain their preferred technique without the increased risk of damage to the soft tissue envelope. The system uses ‘Natural Control Technology’, a proprietary technology that maintains the saw cut plane to help execute precise, reproducible surgeon-controlled cuts without the need for a cutting block. In June this year, Johnson & Johnson
MedTech announced that DePuy Synthes (the Orthopaedics Company of Johnson & Johnson), received 510(k) FDA clearance for the clinical application of the VELYS Robotic-Assisted Solution in Unicompartmental Knee Arthroplasty (UKA). The expanded indication will build upon the VELYS Robotic-Assisted Solution platform used in TKA, which has now been cleared for use in 20 markets and utilised in over 55,000 procedures.
Medtronic In February 2022, Medtronic announced its first procedure in Europe with the Hugo robotic-assisted surgery system. The robotic prostatectomy was performed by Prof. Alexandre Mottrie, head of urology at OLV Hospital in Aalst, Belgium, and chief executive officer and founder of the Belgium-based ORSI Academy, a multidisciplinary centre for training, research and development, and data analysis to improve minimally invasive surgery best practices. At the time of the first procedure, Dr. Mottrie commented: “With more than two decades and 4,000 robotic-assisted surgery procedures under my belt, I am intimately aware of the barriers that have kept the benefits of surgical robotics from physicians, hospitals, and patients. Now, I believe we are entering a new era filled with greater access and flexibility.” The Hugo RAS system is a modular, multi-
quadrant platform designed for a broad range of soft-tissue procedures. It combines wristed instruments, 3D visualisation, and Touch Surgery Enterprise, a cloud-based surgical video capture and management solution, with dedicated support teams specialising in robotics programme optimisation, service, and training. In June 2023, Guy’s and St Thomas’ became
28
www.clinicalservicesjournal.com I October 2024
Versius robot
the first Trust in the UK to adopt the Hugo RAS system. Ben Challacombe, clinical lead for robotic surgery at Guy’s and St Thomas’, said: “We carry out the most robotic operations in the NHS with more than 1,500 cases a year. Expanding our robotics programme with Hugo allows us to offer the benefits of this technology, including fewer complications and smaller scars, to even more patients.” Guy’s and St Thomas’ also partnered with
Proximie to support surgical training on the Hugo RAS system. Surgeons can observe live surgeries via the Proximie platform without needing to be physically present and receive access to recordings of previous surgeries. This provides further opportunities to develop skills to use the system. In April 2023, the Royal National Orthopaedic Hospital (RNOH) also became the first centre in the NHS to successfully conduct a complex spinal surgery in one operation, rather than the usual two, by using another of Medtronic’s surgical robots. A surgical team led by Consultant Spinal Surgeon, Mr Michael Mokawem, undertook the procedure known as an oblique lumbar interbody fusion (OLIF) using the Mazor X Stealth Edition (MXSE) surgical robot. The Mazor is the latest generation of robotic guidance platforms that assist surgeons with sophisticated real-time 3D imaging, advanced anatomy recognition and enhanced navigation that increases surgical precision. OLIF is a minimally invasive procedure that
involves the removal of damaged intervertebral disc and bone, and fusing of two adjacent spinal vertebrae. OLIF is usually completed in two stages due to the complex nature of the procedure: via anterior (the front) and posterior (the back) approaches. Using the Mazor, Mr Mokawem and his team undertook the procedure in a single stage, achieving a first of
its kind in the NHS. Mr Michael Mokawem said: “This is the first time that single position anterior and posterior robotic guided surgery has been done in the NHS. Robotic guided spinal surgery is an exciting technology that augments well-established surgical techniques with the ability to plan screw placement and execute the plan with accuracy, and precision. It allows us to safely operate from the front of the spine and the back of the spine simultaneously compared with the normal procedure of separating the two stages, either on the same day or more commonly on different days which takes longer.” He explained that the procedure involves minimally invasive surgery and decreased tissue damage which leads to an enhanced recovery, while also decreasing the radiation exposure to the theatre team. “There is a large potential time saving through
streamlining patient experience by decreasing total operating time, decreasing length of hospital stay and freeing up more surgical capacity which will improve waiting times for patients,” he added. Dr. Lila Dinner, Chief Medical Officer of the RNOH, said: “RNOH has always been at the forefront of introducing innovative technology into the care and treatment plans for some of our most complex patients. This is a marvellous example of the values we all share to ensure the NHS continues to provide world-class care for all. Medical innovations such as this will help us tackle waiting lists, provide value for money to the NHS and improve patient outcomes. We are enormously proud of the innovative work of our spinal surgical unit.” The Mazor technology is used in both paediatric and adult spinal surgical cases across a range of pathologies including spinal deformity, degenerative spinal disease, traumatic fracture fixation and in the management of spinal cancers.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
